WWL123

WWL123, a carbamate-based compound, is a potent and selective ABHD6 inhibitor. WWL123 can be used for research of inflammation, metabolic disorders (obesity and type II diabetes mellitus) and epilepsy[1].

Product Specifications

CAS Number

[1338574-83-6]

UNSPSC

12352005

Target

MAGL

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/wwl123-1.html

Purity

98.0

Solubility

DMSO : 1 mg/mL (ultrasonic; warming)

Smiles

O=C(C1=CC=C(C2=CC=C(OC(N(CC3=CC=CC(C4=CC=CC=C4)=C3)C)=O)C=C2)C=C1)N

Molecular Formula

C28H24N2O3

Molecular Weight

436.50

References & Citations

[1]Patel JZ, et al. Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors. Bioorg Med Chem. 2015 Oct 1;23 (19) :6335-45.